We Dreamed. We Believed. We Succeeded.
The Journey so Far!
This journey has transformed oncologists to be Asia’s Next-Gen Galens enabling them to fully accelerate Precision Oncology and translate these learnings into their clinics.
This journey has transformed oncologists to be Asia’s Next-Gen Galens enabling them to fully accelerate Precision Oncology and translate these learnings into their clinics.
Dr. Amit Dutt
Principal Investigator,
TMC-ATREC,
Mumbai, India
Dr. Anguraj Sadanandan
Director, The Institute of
Cancer Research,
UK
Dr. Aruna Korlimala
Principal Scientist, Sri Shankara
Cancer Foundation,
Bangalore, India
Dr. Kumar Prabhash
HOD - Medical Oncology,
Tata Memorial Hospital,
Mumbai, India
Dr. Linu Abraham Jacob
HOD - Medical Oncology,
Kidwai Memorial Institute of Oncology,
Bangalore
Dr. Niti Raizada
Director - Medical Oncology,
Fortis Hospitals,
Bangalore, India
Dr. P.K. Julka
Sr.Director - Medical Oncology,
Max Hospital,
Delhi, India
Dr. Sajjan Rajpurohit
Director - Medical Oncology,
BLK-Max Hospital,
Delhi, India
Dr. Sewanti Limaye
Director - Medical Oncology,
Sir H.N. Reliance Foundation Hospital,
Mumbai, India
The first ever Precision Oncology Galens experienced an impressive registration of 80+ participants across Southeast Asia
enrolled for the ever changing Galens course.
Total Registrants across Southeast Asia
Final Year Vs Practicing Oncologists Registered
Speciality -wise registered
Dr.Amit Dutt
Principal Investigator,
TMC-ATREC,
Mumbai, India
Dr. Anguraj Sadanandan
Director, The Institute of
Cancer Research,
UK
Dr. Aruna Korlimala
Principal Scientist, Sri Shankara
Cancer Foundation,
Bangalore, India
Dr.Sajjan Rajpurohit
Director - Medical Oncology,
BLK-Max Hospital,
Delhi, India
Dr. Sewanti Limaye
Director - Medical Oncology,
Sir H.N. Reliance Foundation Hospital,
Mumbai, India
Dr. Vidya Veldore
Clinical Director,
4baseCare
Dr. Vineet Govinda Gupta
Sr. Consultant - Medical Oncology,
Artemis Hospitals,
Gurgaon, India
Yue-Ying Tan
MSc, Manager,
Bioinformatics Sales Specialists,
Illumina APJ
Dr. Ana Carrera
Assoc Director,
Regional Segment Marketing,
Illumina APJ
Dr. Anuradha Chougule
Prof. Medical Onco,
Molecular Lab - TMH,
Mumbai, India
Prof. George Church
Harvard-MIT Health Sciences and Technology,
Cambridge
Dr. Luca Quagliata
Vice Present,
Medical Affairs - Thermo Fisher Scientific
Dr. Pratik Chandrani
Scientist D,
TMC, Mumbai
Dr. Prasenjit Das
Additional Professor - Pathology,
AIIMS, New Delhi
Richa Malhotra
Head of Clinical Informatics & Reporting,
4baseCare
A Comprehensive Curriculum of ~13 hours, the New Age Galens were evaluated through 3 rounds of Critical assessments beginning with the Cross-Examination that assessed critical thinking, and the top 10 participants, who scored > 85%, were selected for the next round.
The second round was the real-life case scenarios which analysed the short-listed participant’s ability to make the right clinical decision and the top 5 participants, who scored > 90%, were chosen for the final round.
The last and final round called the Colloquy examined participants interpreting strategies in context to Precision Oncology thus choosing the final winners of Galens.
We are ecstatic to announce the New-Age Top 5 Galens winners unveiled
in our Precision Oncology Grand Finale
Dr. Anguraj Sadanandan
Final Year - DM Medical Oncology,
Madras Medical College,
Chennai, India
Dr. Amrit Kaur Kaler
Consultant - Molecular Pathology,
Kokilaben Hospital,
Mumbai, India
Dr. Sudip Shrestha
Founder Executive Chairman,
NCHRC,
Kathmandu, Nepal
Dr. Ahmad Sufian
Director - Cancer CRI Centre,
Kaula Lampur,
Malaysia
Dr. Rushabh Kothari
Director - Oncowin Cancer Centre,
Kokilaben Hospital,
Ahmedabad, India
Exhilarated to share a few glimpses of our celebration with our New-Age Galens winners
from our 1st Batch of the Precision Oncology Galens Course
Registration Form